Connect

Member Research and Reports

Member Research and Reports

Colorectal Cancer Treatment Study Raises Troubling Questions for Colorado Researchers

Colorado School of Public Health researchers found that there is a high cost and side effects with little benefits for therapy in senior patients with advanced stage colorectal cancer.

The newer therapy carries more toxicities than many of the older therapies; which may result in patients getting sicker and costing more money with almost no survival benefit. The additional cost associated with the new therapy is also not covered by Medicare.

Many of the patients are paying thousands of dollars out of pocket for the chemotherapies, in addition to the supportive medicines needed to assist patients in coping with the side effects and additional hospital inpatient and outpatient charges.

You can read more, http://www.ucdenver.edu/academics/colleges/PublicHealth/About/news/ResearchNews/Pages/Troubling-Findings-on-Colorectal-Cancer-Treatment-Study.aspx